Sun Pharma breaks away from pure play generic companies in US

R. Sree Ram • November 10, 2025 / 08:34 IST

Sun Pharma’s revenues from specialty drugs surpassed generic medicines for the first time in the US

Sun Pharma has several new drugs in the specialty products pipeline.

To read the full story,

Are you a PRO subscriber? Sign In

Ad free Experience

Seamless navigation, faster responses.
Expert Perspective

Explore 230+ exclusive editorials every month
+

Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights

40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events

Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters

Stay ahead with daily and weekly insights

Unlock exclusive discounts